Miniatura

Fitxers

898600.pdf (2.82 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2025-08-12

Llicència de publicació

cc by (c) Blasco Agell, Lucas et al., 2025
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/223044

LRRK2-mutant microglia and neuromelanin synergize to drive dopaminergic neurodegeneration in an iPSC-based Parkinson’s disease model

Títol de la revista

Autors

ISSN de la revista

Títol del volum

Resum

Parkinson's disease (PD) is a progressive, incurable neurodegenerative disorder characterized by the loss of neuromelanin (NM)-containing dopamine neurons (DAn) in the substantia nigra of the midbrain. Non-neuronal cells are increasingly recognized as contributors to PD. We generated human microglia-like cells (hMG) from induced pluripotent stem cells (iPSC) derived from patients with LRRK2 PD-causing mutations, gene-corrected isogenic controls, and healthy donors. While neither genotype induced neurodegeneration in healthy DAn, LRRK2 hMG become hyperreactive to LPS stimulation, exhibiting increased cytokine expression, reactive oxygen species, and phagocytosis. When exposed to NM-containing particles, but not alpha-synuclein fibrils, LRRK2 hMG trigger DAn degeneration, in a process that is prevented by pre-treatment with the immunomodulatory drug ivermectin. Finally, post-mortem analysis of midbrain tissue of LRRK2-PD patients show increased microglia activation around NM-containing neurons, confirming our in vitro findings. Overall, our work highlights NM-activated microglia's role in PD progression, and provides a model for testing therapeutic targets.

Descripció

Matèries

Matèries (anglès)

Citació

Col·leccions

Articles publicats en revistes (Patologia i Terapèutica Experimental)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Articles publicats en revistes (Institut de Biomedicina (IBUB))

Citació

BLASCO AGELL, Lucas, PONS ESPINAL, Meritxell, TESTA, Veronica, ROCH, Gerard, MONTERO-MUÑOZ, Jara, FERNÁNDEZ CARASA, Irene, BARUFFI, Valentina, GONZALEZ-SEPULVEDA, Marta, RICHAUD-PATIN, Yvonne, JIMENEZ, Senda, CUADROS, Thais, CLADERA-SASTRE, Joana m., COMPTE, Joan, MANGLANO-ARTUÑEDO, Zoe, VENTURA, Salvador, JUAN, Manel, TOLOSA, Eduardo, RAYA CHAMORRO, Ángel, VILA, Miquel, CONSIGLIO, Antonella. LRRK2-mutant microglia and neuromelanin synergize to drive dopaminergic neurodegeneration in an iPSC-based Parkinson’s disease model. _Communications Biology_. 2025. Vol. 8, núm. 1. [consulta: 24 de novembre de 2025]. [Disponible a: https://hdl.handle.net/2445/223044]

Exportar metadades

JSON - METS

Compartir registre